Related Experiment Video
Updated: Sep 28, 2026
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
[A case of preoperative concurrent chemoradiotherapy and curative resection for locally advanced non-small-cell lung
Takao Teruya1, Jiro Ikeda, Masafumi Yamaguchi
1Dept. of Chest Surgery, National Kyushu Cancer Center.
Abstract:
We report the case of a 58-year-old man who underwent complete resection for locally advanced non-small-cell lung cancer (cT4N2M0). The patient received UFT (400 mg/m2 orally on days 1-14 and 22-35) and cisplatin (80 mg/m2 intravenously on days 8, 29) with a total 40 Gy, delivered in 20 fractions on days 1-26. The tumor reduction rate was 76%, and no remarkable toxicities were observed. The patient underwent complete resection and a pathologic complete response was observed. This induction concurrent chemoradiotherapy (followed by surgery) is considered to be effective and safe.
